21 October, 2026 Melbourne, Australia CSL appoints Deborah Waterhouse as CEO & Managing Director The Board of Directors of CSL Limited (ASX:CSL; USOTC:CSLLY) today announces that it has appointed Deborah Waterhouse as Chief Executive Officer and Managing Director of CSL from 1 February 2027. The...
Appointment of New CEO
Filed with ASX ·
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings Call6ix is reading this filing.
Story so far
Earlier from CSL
- CSL dan Alentis umum perkongsian global untuk membangunkan dan mengkomersialkan lixudebart bagi penyakit buah pinggang dan hati yang jarang berlaku
- CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
- CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยาก
- CSL enters exclusive agreement with Alentis Therapeutics
- CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
Later from CSL
All CSL news releasesFollow CSL into a list and get an email when it puts out news.
Follow CSL